Journal
INFLAMMATORY BOWEL DISEASES
Volume 27, Issue 10, Pages 1703-1705Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/ibd/izab114
Keywords
immunization; preventive care; vaccination; Crohn's disease; ulcerative colitis
Categories
Ask authors/readers for more resources
The recent emergency use authorization of a third COVID-19 vaccine means that most patients with inflammatory bowel disease (IBD) will soon be eligible to be vaccinated. Gastroenterology clinicians should be prepared to address patients' concerns regarding safety and efficacy of vaccines, strongly recommend vaccination, and educate patients about logistics for successful vaccination. These measures are crucial to ensure high uptake among patients with IBD.
The recent emergency use authorization of a third COVID-19 vaccine means that most patients with inflammatory bowel disease (IBD) will soon be eligible to be vaccinated. Gastroenterology clinicians should be prepared to address patients' concerns regarding safety and efficacy of vaccines. They should also strongly recommend that all their patients be vaccinated with a COVID-19 vaccine. Additionally, they should be prepared to educate patients about logistics that will result in successful vaccination completion. All these measures will be crucial to ensure high uptake among their patients with IBD.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available